Compare ALG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | WVE |
|---|---|---|
| Founded | 1955 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 1996 | 2015 |
| Metric | ALG | WVE |
|---|---|---|
| Price | $167.72 | $13.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $225.00 | $30.73 |
| AVG Volume (30 Days) | 105.0K | ★ 2.2M |
| Earning Date | 06-03-2026 | 05-29-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.59 | N/A |
| Revenue | ★ $1,603,715,000.00 | $3,704,000.00 |
| Revenue This Year | $8.06 | $16.76 |
| Revenue Next Year | $2.19 | $149.85 |
| P/E Ratio | $20.32 | ★ N/A |
| Revenue Growth | N/A | ★ 149.43 |
| 52 Week Low | $156.30 | $5.28 |
| 52 Week High | $233.29 | $21.73 |
| Indicator | ALG | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 28.38 | 45.40 |
| Support Level | $156.30 | $12.53 |
| Resistance Level | $188.76 | $14.56 |
| Average True Range (ATR) | 8.39 | 0.78 |
| MACD | -5.94 | -0.02 |
| Stochastic Oscillator | 4.41 | 20.34 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.